US 12378248
A1 adenosine receptor agonists and methods of use thereof
granted A61PA61P43/00
Quick answer
US patent 12378248 (A1 adenosine receptor agonists and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P43/00